Amylin Pharmaceuticals Reports Second Quarter Financi...(chnology. Non-GAAP research and developm...),Health

Collaborative profit sharing was $149.2 million for the six months ended June 30, 2009, compared to $148.9 million for the same period in 2008.

Non-GAAP operating loss was $42.2 million for the six months ended June 30, 2009. This was a 50% improvement over the $84.3 million for the same period in 2008. Net loss excluding the restructuring charge was $98.0 million, or $0.70 per share. GAAP net loss for the six months ended June 30, 2009 was $109.3 million, or $0.78 per share, compared to $137.7 million, or $1.01 per share for the same period in 2008.

Conference Call

Amylin will webcast its Quarterly Update Conference Call today at 5:00 p.m. ET/2:00 p.m. PT. Daniel M. Bradbury, Amylin's president and chief executive officer, will lead the call. During the call, the Company plans to provide further details underlying its quarterly financial results, and information regarding assumptions for the remainder of 2009 operations.

The call will be webcast live through the "Investors" section of Amylin's corporate Web site at www.amylin.com. A slide presentation accompanying the conference call will also be available through the "Investors" section of Amylin's corporate Web site. To access the webcast and slide presentation, please log on to www.amylin.com approximately fifteen minutes prior to the call to register, download and install any necessary audio software. For those without access to the Internet, the live call may be accessed by phone by calling (866) 783-2141 (U.S./Canada) or (857) 350-1600 (international), Conference ID# 46259840. A replay of the call will be available through the "Investors" section of Amylin'
'/>"/>